Eshwary Yerramsetty, Touro College of Pharmacy, PharmD Candidate 2014

All articles by Eshwary Yerramsetty, Touro College of Pharmacy, PharmD Candidate 2014

Updates in Breast Cancer Risk Reduction

By

Eshwary Yerramsetty, Touro College of Pharmacy, PharmD Candidate 2014

July 26, 2013

ASCO recently released new guidelines on the use of tamoxifen, raloxifene, or exemestane for decreasing the risk of invasive breast cancer.

Next post in Breast Cancer

Automated Variation Measure Indicates Risk of Breast Cancer

Nodal Mets Common in Breast Cancers with Certain Mutations